{"title":"Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1KO mice","authors":"Yichen Yang, Zhihe Xue, Jiayong Lai, Jinglan Zhang, Changmiao Pang, Jinglin Zhong, Zhanpeng Kuang, Baojuan Zou, Yaqing Liu, Liangzhong Sun","doi":"10.1002/ctm2.70245","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Nephronophthisis (NPH) is an autosomal recessive interstitial cystic kidney disease, which is the most common genetic cause of end-stage renal disease (ESRD) in childhood. The Hippo pathway is regulated by the cilium and has been suggested to be linked to NPH. The aim of the study was to investigate the involvement of Hippo pathway in the pathogenesis of <i>nphp1</i> defect-associated NPH (NPH1).</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p><i>Nphp1</i> knockout (<i>nphp1</i><sup>KO</sup>) Madin-Darby Canine Kidney (MDCK) cells and <i>nphp1</i><sup>KO</sup> C57BL/6J mice were generated via CRISPR gene editing strategy. The siRNAs targeting <i>Kibra</i>, <i>MST1</i> and <i>LATS1</i> were designed. An AAV9 vector was designed for <i>Kibra</i> knockdown. The expression and phosphorylation of core Hippo pathway molecules were evaluated. Pathological renal changes were evaluated via light microscopy respectively with haematoxylin–eosin and Masson staining.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In <i>nphp1</i><sup>KO</sup> MDCK cells, <i>nphp1</i><sup>KO</sup> mice and NPH1 patients’ kidneys, Kibra, p-MST1/2, p-LATS and p-YAP exhibited a notable increase in levels, with an even greater elevation observed in renal cyst cells, indicating the Hippo pathway activated in these <i>nphp1</i>-deficient contexts. <i>Nphp1</i> re-expression reversed the Hippo pathway activation in cells, indicating that the Hippo pathway activation is related to <i>nphp1</i> deficiency in vitro. Meanwhile, in vitro, <i>MST1</i> knockdown downregulated LATS1 and YAP phosphorylation, <i>LATS1</i> knockdown downregulated YAP phosphorylation, suggesting the activation of the canonical Hippo pathway in <i>nphp1</i>-deficient contexts. Knockdown of the upstream regulator <i>Kibra</i> inhibited the Hippo pathway activation in both <i>nphp1</i><sup>KO</sup> MDCK cells and mice. Following <i>Kibra</i> knockdown, the organisation of <i>nphp1</i><sup>KO</sup> MDCK cells became more compact, the intensity of the actin fibres increased. Besides, decreased renal fibrosis and cyst formation were observed in <i>nphp1</i><sup>KO</sup> mice.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The canonical Hippo pathway is aberrantly activated in <i>nphp1</i>-deficient conditions. <i>Kibra</i> may serve as a crucial upstream regulator of <i>nphp1</i> deficiency-related Hippo pathway activation. <i>Kibra</i> upregulation and activation of the Hippo pathway are involved in the pathogenesis of NPH1.</p>\n </section>\n \n <section>\n \n <h3> Key Points</h3>\n \n <div>\n <ul>\n \n <li>Canonical Hippo pathway activated in <i>nphp1</i>-deficient disease models and patients.</li>\n \n <li>Kibra was a key upstream molecule in regulating the activation of canonical Hippo pathway in <i>nphp1</i>-deficient disease models and patients and closely related to renal cyst formation and fibrosis in <i>nphp1</i><sup>KO</sup> mice.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 3","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70245","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70245","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Nephronophthisis (NPH) is an autosomal recessive interstitial cystic kidney disease, which is the most common genetic cause of end-stage renal disease (ESRD) in childhood. The Hippo pathway is regulated by the cilium and has been suggested to be linked to NPH. The aim of the study was to investigate the involvement of Hippo pathway in the pathogenesis of nphp1 defect-associated NPH (NPH1).
Method
Nphp1 knockout (nphp1KO) Madin-Darby Canine Kidney (MDCK) cells and nphp1KO C57BL/6J mice were generated via CRISPR gene editing strategy. The siRNAs targeting Kibra, MST1 and LATS1 were designed. An AAV9 vector was designed for Kibra knockdown. The expression and phosphorylation of core Hippo pathway molecules were evaluated. Pathological renal changes were evaluated via light microscopy respectively with haematoxylin–eosin and Masson staining.
Results
In nphp1KO MDCK cells, nphp1KO mice and NPH1 patients’ kidneys, Kibra, p-MST1/2, p-LATS and p-YAP exhibited a notable increase in levels, with an even greater elevation observed in renal cyst cells, indicating the Hippo pathway activated in these nphp1-deficient contexts. Nphp1 re-expression reversed the Hippo pathway activation in cells, indicating that the Hippo pathway activation is related to nphp1 deficiency in vitro. Meanwhile, in vitro, MST1 knockdown downregulated LATS1 and YAP phosphorylation, LATS1 knockdown downregulated YAP phosphorylation, suggesting the activation of the canonical Hippo pathway in nphp1-deficient contexts. Knockdown of the upstream regulator Kibra inhibited the Hippo pathway activation in both nphp1KO MDCK cells and mice. Following Kibra knockdown, the organisation of nphp1KO MDCK cells became more compact, the intensity of the actin fibres increased. Besides, decreased renal fibrosis and cyst formation were observed in nphp1KO mice.
Conclusions
The canonical Hippo pathway is aberrantly activated in nphp1-deficient conditions. Kibra may serve as a crucial upstream regulator of nphp1 deficiency-related Hippo pathway activation. Kibra upregulation and activation of the Hippo pathway are involved in the pathogenesis of NPH1.
Key Points
Canonical Hippo pathway activated in nphp1-deficient disease models and patients.
Kibra was a key upstream molecule in regulating the activation of canonical Hippo pathway in nphp1-deficient disease models and patients and closely related to renal cyst formation and fibrosis in nphp1KO mice.
期刊介绍:
Clinical and Translational Medicine (CTM) is an international, peer-reviewed, open-access journal dedicated to accelerating the translation of preclinical research into clinical applications and fostering communication between basic and clinical scientists. It highlights the clinical potential and application of various fields including biotechnologies, biomaterials, bioengineering, biomarkers, molecular medicine, omics science, bioinformatics, immunology, molecular imaging, drug discovery, regulation, and health policy. With a focus on the bench-to-bedside approach, CTM prioritizes studies and clinical observations that generate hypotheses relevant to patients and diseases, guiding investigations in cellular and molecular medicine. The journal encourages submissions from clinicians, researchers, policymakers, and industry professionals.